Atomistry » Fluorine » PDB 4q0e-4qrc » 4q1e
Atomistry »
  Fluorine »
    PDB 4q0e-4qrc »
      4q1e »

Fluorine in PDB 4q1e: Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}

Enzymatic activity of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}

All present enzymatic activity of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}:
2.7.1.74;

Protein crystallography data

The structure of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}, PDB code: 4q1e was solved by J.Nomme, A.Lavie, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 27.92 / 1.85
Space group P 41
Cell size a, b, c (Å), α, β, γ (°) 68.736, 68.736, 122.206, 90.00, 90.00, 90.00
R / Rfree (%) 17.4 / 21.8

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} (pdb code 4q1e). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}, PDB code: 4q1e:
Jump to Fluorine binding site number: 1; 2; 3; 4;

Fluorine binding site 1 out of 4 in 4q1e

Go back to Fluorine Binding Sites List in 4q1e
Fluorine binding site 1 out of 4 in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F301

b:53.3
occ:1.00
 FAF A:2Y8301 0.0 53.3 1.0
CAK A:2Y8301 1.3 53.7 1.0
CAL A:2Y8301 2.2 54.3 1.0
OG A:SER144 2.6 30.2 0.5
OG A:SER144 2.9 38.5 0.5
CB A:SER144 2.9 34.7 0.5
CB A:SER144 3.0 38.3 0.5
OD1 A:ASN140 3.4 37.0 1.0
OAQ A:2Y8301 3.4 51.1 1.0
CD2 A:LEU141 3.5 29.1 1.0
O A:ASN140 3.7 32.0 1.0
CA A:LEU141 3.9 30.0 1.0
CE1 A:TYR204 3.9 37.5 1.0
C A:ASN140 4.0 33.6 1.0
N A:LEU141 4.1 30.6 1.0
CG A:ASN140 4.1 34.7 1.0
OG A:SER146 4.2 37.4 1.0
CA A:SER144 4.4 33.8 0.5
CA A:SER144 4.4 35.5 0.5
O A:HOH460 4.5 35.6 1.0
CAY A:2Y8301 4.5 47.0 1.0
CD1 A:TYR204 4.5 37.5 1.0
CG A:LEU141 4.5 29.1 1.0
CB A:LEU141 4.7 30.2 1.0
N A:SER144 4.7 33.2 1.0
ND2 A:ASN140 4.7 35.0 1.0
CAJ A:2Y8301 4.8 43.5 1.0
CB A:ASN140 4.8 33.1 1.0
C A:LEU141 4.9 30.2 1.0
CZ A:TYR204 4.9 40.5 1.0
OH A:TYR204 5.0 47.6 1.0

Fluorine binding site 2 out of 4 in 4q1e

Go back to Fluorine Binding Sites List in 4q1e
Fluorine binding site 2 out of 4 in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F302

b:52.1
occ:1.00
 FAF A:2Y7302 0.0 52.1 1.0
CAK A:2Y7302 1.2 47.8 1.0
CAL A:2Y7302 2.2 45.2 1.0
OH A:TYR86 3.1 55.8 1.0
OAQ A:2Y7302 3.3 45.5 1.0
CZ A:TYR86 3.9 51.1 1.0
CAY A:2Y7302 4.5 44.3 1.0
CE2 A:TYR86 4.5 48.4 1.0
O A:GLY199 4.7 40.5 1.0
CE1 A:TYR86 4.8 51.2 1.0

Fluorine binding site 3 out of 4 in 4q1e

Go back to Fluorine Binding Sites List in 4q1e
Fluorine binding site 3 out of 4 in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F301

b:54.5
occ:1.00
 FAF B:2Y8301 0.0 54.5 1.0
CAK B:2Y8301 1.2 50.4 1.0
CAL B:2Y8301 2.2 48.6 1.0
OG B:SER144 3.0 32.9 0.5
CB B:SER144 3.3 35.8 0.5
OAQ B:2Y8301 3.3 43.8 1.0
CB B:SER144 3.3 37.2 0.5
OG B:SER144 3.5 35.6 0.5
OG B:SER146 4.3 36.2 1.0
CE1 B:TYR204 4.4 45.4 1.0
CAY B:2Y8301 4.5 43.0 1.0
CD1 B:TYR204 4.6 49.0 1.0
CA B:SER144 4.7 35.8 0.5
CAA B:2Y7302 4.7 41.0 1.0
CA B:SER144 4.7 35.1 0.5
O B:SER144 4.8 38.4 1.0
O B:HOH424 4.9 38.3 1.0
NZ B:LYS207 5.0 55.0 1.0

Fluorine binding site 4 out of 4 in 4q1e

Go back to Fluorine Binding Sites List in 4q1e
Fluorine binding site 4 out of 4 in the Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine}


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Human Dck C4S-S74E Mutant in Complex with Udp and the Inhibitor 10 {2- {[(1R/S)-1-{2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Methyl-1,3- Thiazol 4-Yl}Ethyl]Sulfanyl}Pyrimidine-4,6-Diamine} within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F302

b:61.2
occ:1.00
 FAF B:2Y7302 0.0 61.2 1.0
CAK B:2Y7302 1.4 59.2 1.0
CAL B:2Y7302 2.3 54.9 1.0
OAQ B:2Y7302 2.5 52.2 1.0
OH B:TYR86 2.8 49.1 1.0
CZ B:TYR86 3.4 46.0 1.0
CAY B:2Y7302 3.8 45.9 1.0
CE2 B:TYR86 3.9 44.6 1.0
CE1 B:TYR86 4.2 45.5 1.0
CAJ B:2Y7302 4.4 42.7 1.0
CAA B:2Y8301 4.5 40.3 1.0
O B:GLY199 4.8 43.6 1.0
CAX B:2Y7302 4.9 43.5 1.0
OAP B:2Y7302 4.9 42.0 1.0

Reference:

J.Nomme, Z.Li, R.M.Gipson, J.Wang, A.L.Armijo, T.Le, S.Poddar, T.Smith, B.D.Santarsiero, H.A.Nguyen, J.Czernin, A.N.Alexandrova, M.E.Jung, C.G.Radu, A.Lavie. Structure-Guided Development of Deoxycytidine Kinase Inhibitors with Nanomolar Affinity and Improved Metabolic Stability. J.Med.Chem. 2014.
ISSN: ISSN 0022-2623
PubMed: 25341194
DOI: 10.1021/JM501124J
Page generated: Thu Aug 1 05:08:51 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy